Class II · ModerateActive recall
Apothecary NAD+ Injection 200 mg/mL
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberLot #: AP-202647, BUD 13-Oct-2026
Where it was soldNationwide within the United States
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Lack of Assurance of Sterility
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
| Distributed by / for | Apothecary Pharma LLC |
| NDC | 85091-011-06 |
Show the full FDA record
| Full product label | Apothecary NAD+ Injection 200 mg/mL, 6 mL Sterile Multi-Dose Vial, Rx Only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC, 27513, NDC 85091-011-06. |
| Recalling firm | Apothecary Pharma LLC |
| Distribution | Nationwide within the United States |
| Quantity | 1 vial |
| Recall initiated | 2026-09-24 |
| Report date | 2026-10-14 |
| Recall completed | — |
| Recall number | D-0037-2027 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Cary NC United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.